How Do You Respond To The Future Of Clinical Research

838 Words2 Pages

Envisioning the Future of Clinical Research
Clinical Research in 2025 May 28th, 2000, my first day working in clinical research. A lot of time, a lot of experiences, a lot of changes. Everyone who has worked in clinical research has passed thru many changes. However, in my experience, clinical research main activities have not changed in its essence, changes have been done in the how but not in the what. And clinical research is not the one which generates the changes. Changes come in response to those external forces directly related such as changes in medicine, pharmacology, economy, society, environment and changes in the people way of living, thinking or fall sick. Principal changes have been done in the use of technology to facilitate …show more content…

A sponsor will still be focused in ensure all data collected is accurate, real and reliable. Timelines and competition will lead to look for ways to work and achieve objectives in less time. However, this increasing request of achieve results in less time, will lead to a different way to work. Subjects will be completely replaced by data, having all the required information as the focus; detailed supervision of sites performance will be replaced by a remote monitoring in which taking risks will be the focus. It is important then to work in having sites completely autonomous and well trained in the way data is collected and recorded. The work of the clinical research associate will be focused in the selection of the most appropriate sites and in their preparation to develop a protocol and transmission of the real objective of clinical research, develop accurate medications to ease human life. Understanding the why will ease the understanding and acceptance of …show more content…

Let´s review three areas in which, in my opinion, will be the main changes:
1. Remote Monitoring: Risk based monitoring will be the way research companies will be working in 2025. Sites will be completely responsible and accountable of the data collected and Sponsors must ensure site is adequately prepared to be the one to complete quality control and quality assurance tasks. Supervision will be based in the raw data, and performance evaluation will be done based on the revision of tendencies. Sponsor responsibility will be in the selection and preparation of sites. Regulatory documents will be shared electronically.
2. Remote participation: Distances will not be a problem. Study visits and procedures will be done via video conference; data will be recorded by the subjects and transmitted to the site. Exams could be performed by standard machines used in the standard of care. Medication intake will be monitored remotely with technological devices and artificial machines will be the reminders. Consent forms could be

Open Document